Inventor
SANTUS GIANCARLO
IT28 patents
⚠️ This page may combine multiple inventors who share the name “SANTUS GIANCARLO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RECORDATI CHEM PHARM
14 patentsUS6214386B1Apr 10, 2001
Prompt-release oral pharmaceutical compositions for extemporaneous suspensions
RECORDATI CHEM PHARM123 citations96
US5952021ASep 14, 1999
Stabilized biologically active compounds contained in coated microgranules which can be suspended in alimentary fluids
RECORDATI CHEM PHARM70 citations96
US5674533AOct 7, 1997
Pharmaceutical composition for the controlled release of moguisteine in a liquid suspension
RECORDATI CHEM PHARM1,649 citations96
US5472704ADec 5, 1995
Pharmaceutical controlled-release composition with bioadhesive properties
RECORDATI CHEM PHARM259 citations96
US6333044B1Dec 25, 2001
Therapeutic compositions for intranasal administration which include KETOROLAC®
RECORDATI CHEM PHARM53 citations95
US5527545AJun 18, 1996
Liquid-suspension controlled-release pharmaceutical composition
RECORDATI CHEM PHARM66 citations95
US5460828AOct 24, 1995
Process for the preparation of microgranules suitable for suspension in fluids
RECORDATI CHEM PHARM74 citations95
US5296236AMar 22, 1994
Controlled release therapeutic system for a liquid pharmaceutical formulations
RECORDATI CHEM PHARM53 citations95
US5571533ANov 5, 1996
Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
RECORDATI CHEM PHARM111 citations94
US5670171ASep 23, 1997
Liquid-suspension controlled-release pharmaceutical composition
RECORDATI CHEM PHARM30 citations92
US5510119AApr 23, 1996
Controlled release therapeutic system for liquid pharmaceutical formulations
RECORDATI CHEM PHARM25 citations91
US5405619AApr 11, 1995
Controlled release therapeutic system for liquid pharmaceutical formulations
RECORDATI CHEM PHARM13 citations72
US5165937ANov 24, 1992
Controlled release tablets containing flavoxate
RECORDATI CHEM PHARM11 citations71
US7267827B2Sep 11, 2007
Therapeutic compositions for intranasal administration which include KETOROLAC
RECORDATI CHEM PHARM2 citations62
NICOX SA
4 patentsUS7199258B2Apr 3, 2007
Process for preparing nitrooxyderivatives of naproxen
NICOX SA7 citations74
US7776902B2Aug 17, 2010
Nitrooxyderivatives of cyclooxygenase-2 inhibitors
NICOX SA3 citations63
US7723382B2May 25, 2010
Process for preparing nitrooxyalkyl substituted esters of carboxylic acids, intermediates useful in said process and preparation thereof
NICOX SA3 citations63
US7166605B2Jan 23, 2007
Probucol nitro-derivatives
NICOX SA4 citations63
PHARMACIA AB
2 patentsFLORA INC
2 patentsFIRST WAVE BIO INC
2 patentsUS10292951B2May 21, 2019
Methods and compositions for treating conditions associated with an abnormal inflammatory responses
FIRST WAVE BIO INC9 citations92
US10772854B2Sep 15, 2020
Methods and compositions for treating conditions associated with an abnormal inflammatory response
FIRST WAVE BIO INC6 citations83
EMS SA
2 patentsUS10086002B2Oct 2, 2018
Dosage forms containing fluticasone propionate for the treatment of inflammatory conditions of the esophagus
EMS SA0 citations36
US9980975B2May 29, 2018
Dosage forms containing fluticasone propionate for the treatment of inflammatory conditions of the esophagus
EMS SA0 citations36